Investor insights
Sectors invested in
Biotechnology5
Therapeutics4
Medical4
Health Diagnostics2
Life Science2
Antibodies2
Cancer vaccines2
Chimeric Antigen Receptor - T Cells2
Companion diagnostics2
Immuno-oncology2
biotechnology1
Health Care1
Reproductive Health1
Women's health1
Drug Development1
Ovarian Physiology1
Healthspan1
Longevity1
Funding rounds participated in
$30M sweet spot round size
Most of their 5 investments are in rounds between $11M and $31M
Basic info
Industry
biotechnology research
Sectors
Biotechnology
Biopharma
Life Science
Date founded
2019
Investments made
V
Vita Therapeutics raised $31M on October 12, 2022
Investors: Solve FSHD, Riptide Ventures and Cambrian Bio
O
Oviva Therapeutics raised $12M on May 19, 2022
Investors: Cambrian Bio
V
Vita Therapeutics raised $32M on June 23, 2021
Investors: Early Light Ventures and Cambrian Bio
S
Sensei Bio raised $30M on January 11, 2021
Investors: infinitas capital, Catalio Capital Management, Korify Capital AG, Apeiron Investment Group, Future Ventures, Presight Capital, Pura Vida Investments and Cambrian Bio
S
Sensei Bio raised $29M on October 7, 2020
Investors: Future Ventures, Presight Capital, Apeiron Investment Group and Cambrian Bio